• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics

Posted on: Monday, 30 March 2009, 07:00 CDT

A Complimentary Webinar

MOUNTAIN VIEW, Calif., March 30 /PRNewswire/ --

- TOPIC: The state of the microRNA market and the molecule's current and potential impact on drug discovery, molecular diagnostics, and personalized therapeutics. - WHEN: Tuesday, March 31, 2009 - TIME: 3 pm EDT - LOCATION: Online with free registration - HOST: Christi Bird, Senior Research Analyst, Healthcare practice, Frost & Sullivan - GUESTS: - Dr. George Calin, Associate Professor, The University of Texas M. D. Anderson Cancer Center - Alex Amiet, Senior Product Manager, Thermo Fisher Scientific - This panel discussion will benefit life science research tools manufacturers, services providers, diagnostic companies, biotechnology companies, pharmaceutical companies, academic researchers and venture capitalists. The outlook for the microRNA market will be presented from a three-pronged perspective of an industry analyst with knowledge of the market, a microRNA expert from academia, and a provider of microRNA tools and services.

Supporting Quote

"The rapid discoveries linking microRNAs to various diseases have propelled the microRNA field and tools market in recent years. Moving forward, however, the microRNA field requires more innovative studies of larger scope to make good on its lofty promise," says Bird of Frost & Sullivan.

Supporting Resources

To participate, please email Stephanie Ochoa, stephanie.ochoa@frost.com, with the following information: your full name, title, company name, company telephone number, company email address, city, state and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.

Frost & Sullivan's Drug Discovery practice: www.frost.com/drugdiscovery

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Contact: Stephanie Ochoa Frost & Sullivan +1.210.247.2421 stephanie.ochoa@frost.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

SOURCE Frost & Sullivan

Source: PR Newswire

More News in this Category